Oliveira, M., Sonnenblick, A., Stemmer, S. M., Gion, M., Im, S., Bermejo, B., Yam, E. G., Sohn, J., Wander, S. A., Rugo, H. S., Park, Y. H., Cahuzac, C., Collier, A., Ngo, H. X., Retiere, A., Schwab, R. B., Zhu, J., Jung, K. H. (2025). Giredestrant (G) with atezolizumab (ATEZO), and/or abemaciclib (ABEMA) in patients (pts) with ER+/HER2– locally advanced/metastatic breast cancer (LA/mBC): Interim analysis (IA) from the phase I/II MORPHEUS Breast Cancer study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.1061